Outcomes of single- and two-stage revision total knee arthroplasty for chronic periprosthetic joint infection

医学 假体周围 生存曲线 外科 队列 关节置换术 比例危险模型 内科学 回顾性队列研究 阶段(地层学) 癌症 生物 古生物学
作者
Hosam E. Matar,Benjamin V. Bloch,S. Snape,Peter James
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:103-B (8): 1373-1379 被引量:66
标识
DOI:10.1302/0301-620x.103b8.bjj-2021-0224.r1
摘要

Aims Single-stage revision total knee arthroplasty (rTKA) is gaining popularity in treating chronic periprosthetic joint infections (PJIs). We have introduced this approach to our clinical practice and sought to evaluate rates of reinfection and re-revision, along with predictors of failure of both single- and two-stage rTKA for chronic PJI. Methods A retrospective comparative cohort study of all rTKAs for chronic PJI between 1 April 2003 and 31 December 2018 was undertaken using prospective databases. Patients with acute infections were excluded; rTKAs were classified as single-stage, stage 1, or stage 2 of two-stage revision. The primary outcome measure was failure to eradicate or recurrent infection. Variables evaluated for failure by regression analysis included age, BMI, American Society of Anesthesiologists grade, infecting organisms, and the presence of a sinus. Patient survivorship was also compared between the groups. Results A total of 292 consecutive first-time rTKAs for chronic PJI were included: 82 single-stage (28.1%); and 210 two-stage (71.9%) revisions. The mean age was 71 years (27 to 90), with 165 females (57.4%), and a mean BMI of 30.9 kg/m 2 (20 to 53). Significantly more patients with a known infecting organism were in the single-stage group (93.9% vs 80.47%; p = 0.004). The infecting organism was identified preoperatively in 246 cases (84.2%). At a mean follow-up of 6.3 years (2.0 to 17.6), the failure rate was 6.1% in the single-stage, and 12% in the two-stage groups. All failures occurred within four years of treatment. The presence of a sinus was an independent risk factor for failure (odds ratio (OR) 4.97; 95% confidence interval (CI) 1.593 to 15.505; p = 0.006), as well as age > 80 years (OR 5.962; 95% CI 1.156 to 30.73; p = 0.033). The ten-year patient survivorship rate was 72% in the single-stage group compared with 70.5% in the two-stage group. This difference was not significant (p = 0.517). Conclusion Single-stage rTKA is an effective strategy with a high success rate comparable to two-stage approach in appropriately selected patients. Cite this article: Bone Joint J 2021;103-B(8):1373–1379.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1234hai完成签到 ,获得积分10
刚刚
YY的应助被TFL采纳,获得10
刚刚
任风完成签到,获得积分0
1秒前
大小罐子发布了新的文献求助10
1秒前
初景的应助被机智戴夫采纳,获得20
2秒前
wtttt发布了新的文献求助10
2秒前
哈哈上将完成签到,获得积分10
4秒前
5秒前
111完成签到 ,获得积分10
6秒前
dddddd完成签到,获得积分10
9秒前
9秒前
Exotic完成签到,获得积分10
10秒前
12秒前
科研通AI6.2的应助被江舁采纳,获得10
12秒前
馍夹肉完成签到 ,获得积分10
12秒前
wyyy发布了新的文献求助10
12秒前
星辰大海的应助被111采纳,获得10
15秒前
sunburst发布了新的文献求助10
16秒前
BANLAN完成签到,获得积分10
17秒前
wtttt完成签到,获得积分20
18秒前
坦率的柏柳完成签到 ,获得积分10
19秒前
20秒前
123完成签到,获得积分10
20秒前
Aragon完成签到,获得积分10
20秒前
bkagyin的应助被虎杖悠仁采纳,获得10
21秒前
21秒前
22秒前
sunburst完成签到,获得积分20
25秒前
guangwow完成签到,获得积分10
26秒前
Crssss发布了新的文献求助10
26秒前
柿莴发布了新的文献求助10
26秒前
27秒前
27秒前
ssmffryjj888完成签到,获得积分10
27秒前
28秒前
学霸业的应助被爱吃蛋挞采纳,获得10
28秒前
28秒前
29秒前
香蕉觅云的应助被浪里个浪漫采纳,获得20
29秒前
十二月发布了新的文献求助10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Modern Artificial Intelligence 1000
Особенности технологий и методов информационно-психологических войн СССР с Великобританией и США в период 1939-1953 гг 1000
Das Matthäusevangelium: Kapitel 1:1–17 1000
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 600
Cellulose and Cellulose Derivatives: Synthesis, Modification and Applications 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8141841
求助须知:如何正确求助?哪些是违规求助? 9541624
关于积分的说明 21647256
捐赠科研通 7726054
什么是DOI,文献DOI怎么找? 3421444
关于科研通互助平台的介绍 2546626
邀请新用户注册赠送积分活动 2463815